Danaher Corporation (NYSE:DHR) stock has experienced a notable downturn, reaching a 52-week low of $225.36. With a market ...

Danaher's Q4 earnings missed expectations due to a decline in its diagnostics segment, despite stronger sales in ...

Danaher (DHR) stock trades ~5% lower as the company, with its Q4 2024 results, projects a sales contraction in the current ...

Stifel analysts reduced the price target for Danaher Corporation shares (NYSE:DHR) to $260 from the previous target of $265, while maintaining a Hold rating on the stock. The new target sits within ...

U.S. stocks slipped after the Federal Reserve held its main interest rate steady and broke a run of cuts that began in ...

The average estimate of nine analysts surveyed by Zacks Investment Research was for earnings of $2.17 per share. The industrial and medical device maker posted revenue of $6.54 billion in the period, ...

The stock's fall snapped a five-day winning streak.

Danaher Corp. (DHR) released earnings for its fourth quarter that increased from last year but missed the Street estimates. The ...

Shares of Danaher Corp. DHR rose 1.95% to $250.59 Monday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average DJIA rising 0.65% to ...

This positive outcome has rippled through the industry, with Danaher and Thermo Fisher anticipating their own earnings reports later this week. Analysts have weighed in on Sartorius's results, ...

Danaher (DHR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations. Beckman Coulter Diagnostics, a ...